Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix
- 1 November 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 43 (2) , 145-148
- https://doi.org/10.1016/0090-8258(91)90061-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Combination Bleomycin, Ifosfamide, and Cisplatin Chemotherapy in Cervical CancerJNCI Journal of the National Cancer Institute, 1989
- Chemotherapy for advanced or recurrent gynecologic cancerCancer, 1987
- Testing IFO/Mesna and VP-16 Combination Therapy in the P388 Leukemia ModelPublished by S. Karger AG ,1987
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985
- Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Current development of podophyllotoxinsCancer Chemotherapy and Pharmacology, 1982